Actively Recruiting
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
Led by Northern Jiangsu People's Hospital · Updated on 2026-03-04
336
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of the combination therapy of hydrocortisone and fludrocortisone among adult patients with septic shock.
CONDITIONS
Official Title
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged between 18 and 90 years
- Diagnosis of septic shock within 12 hours prior to enrollment
You will not qualify if you...
- Use of systemic corticosteroid therapy within the last 3 months before septic shock
- Receiving high-dose steroid therapy
- Having immunosuppression
- Being pregnant
- Known allergy to hydrocortisone or fludrocortisone
- Presence of gastrointestinal bleeding, perforation, or conditions requiring fasting
- Expected death from a preexisting disease within 90 days after randomization
- Refusal by attending staff or patient's family
- Current participation in another clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China, 225000
Actively Recruiting
Research Team
Q
Qingquan Lyu, Master
CONTACT
X
Xiaohua Gu, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here